What BioSAFE Engineering does

BioSAFE Engineering designs, manufactures, installs, and services non-incineration waste treatment equipment for healthcare and life sciences customers. The company was organized in 2007 as BioSAFE Engineering LLC and operates from a 55,000 ft2 manufacturing facility in Indianapolis, with service coverage spanning North America, Europe, and Asia. It serves four primary verticals: hospitals and healthcare systems, life science and BSL-2 through BSL-4 research facilities, pharmaceutical and biotech manufacturers, and government/defense research institutions, with notable customers including GSK, Pfizer, Takeda, Mayo Clinic, Geisinger Medical Center, Boston University, and a major government BSL-3/4 facility.

The company's product portfolio is built on three proprietary technology platforms: the STI Medical Waste Treatment System, which combines low-pressure steam with integrated shredding to achieve up to 6-log pathogen reduction and 90% bulk reduction for solid medical waste; Effluent Decontamination Systems (EDS) for liquid waste, offered in continuous-flow and batch configurations with thermal-based, chemical-free neutralization and heat-recovery options; and Tissue Digesters using alkaline hydrolysis that achieve 97% mass reduction and support prion destruction. The portfolio is anchored by patented prion destruction and inactivation technology, and is organized into three divisions: BioSAFE Life Science Solutions, BioSAFE Medical Waste Systems, and BioSAFE Advance Engineering Services.

BioSAFE generates revenue through customized hardware sales and recurring service, validation, commissioning, and system-modernization contracts, with pricing set on a facility-specific basis depending on waste volume, throughput, and containment requirements. Go-to-market is exclusively direct enterprise field sales, supported by a content marketing engine (WasteWise YouTube series, blog, case studies, and a savings calculator) that captures top-of-funnel demand. The company is privately held and led by CEO Phillip Mervis, with a recently built-out commercial team including CCO Daniel A. Nelsen (Stanford engineering background) and Director of Sales and Marketing Aaron Stout (formerly of Thermo Fisher Scientific and Helmer Scientific). No external funding rounds, acquisitions, or parent company are disclosed.

Name

BioSAFE Engineering

Legal name

BioSAFE Engineering LLC.

Website

https://biosafeeng.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

BioSAFE Engineering manufactures and services non-incineration waste treatment systems — including the STI solid waste system, Effluent Decontamination Systems for liquid waste, and alkaline-hydrolysis Tissue Digesters — for hospitals, life science laboratories, pharmaceutical manufacturers, and government research facilities worldwide.

Ownership category

akta.pro rank

Product category

Medical Waste Treatment Equipment

NAICS

Hazardous Waste Treatment and Disposal (562211), Waste Treatment and Disposal (56221), Waste Treatment and Disposal (5622), Sewage Treatment Facilities (221320)

SIC

Hazardous Waste Management (4955), Refuse Systems (4953)

akta.pro primary industry

Medical Waste Treatment (Autoclave/Microwave/Chemical) (BPALAGAB)

akta.pro secondary industries

Medical & Biohazardous Waste Management (RMW, Sharps, Pathological) (EUAIAFAE), Medical Waste Management & Biohazard Disposal Systems (Regulated Waste, Liners, Containers) (HLAHANAI), Medical & Biohazardous Waste Support (On-site Regulated Waste Staging) (BPABALAH), Bioprocess Safety, Biosafety & Contamination Control Solutions (single-use integrity, environmental monitoring) (HLAAAJAO)

Keywords

• Biomedical waste treatment
• Medical waste systems
• Effluent decontamination systems
• Alkaline hydrolysis digesters
• Biocontainment waste solutions

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Waste Treatment Systems: Sale of STI Medical Waste Treatment Systems for hospitals and medical facilities. Systems provide on-site waste decontamination and disposal with lowest operating costs in the industry. Pricing is facility-specific based on waste volume and throughput requirements.
2. Effluent Decontamination Systems: Sale and installation of EDS units for liquid waste treatment in life science and healthcare facilities. Systems are customized per facility requirements including containment levels (PC/BSL 2-4) and processing volumes.
3. Tissue Digesters: Sale of alkaline hydrolysis tissue digesters ranging from lab-scale (5 kg/cycle) to large-scale (500 lb/cycle) and trailer-mounted mobilized units. Equipment converts tissue waste to sterile effluent.
4. Service, Validation, and Commissioning: Full-service support including installation, commissioning, on-site training, and ongoing maintenance. Factory-direct service technicians plus authorized service groups provide global coverage with 2-hour response guarantee and 24-hour on-site service commitment.
5. Custom Engineering Services: Custom-engineered solutions for complex regulated waste challenges including emergency deployment and crisis management situations. Includes system modernization and retrofit services for existing facilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

BioSAFE Engineering designs, manufactures, installs, and services non-incineration waste treatment equipment for healthcare and life sciences. Its portfolio includes the STI Medical Waste Treatment System for solid/red-bag infectious waste, Effluent Decontamination Systems (EDS) for liquid biocontainment waste, and Tissue Digesters using alkaline hydrolysis, complemented by custom engineering and validation/commissioning services.

Product overview

BioSAFE Engineering offers a portfolio of three core eco-friendly waste treatment product lines—STI Medical Waste Treatment Systems for solid medical waste, Effluent Decontamination Systems for liquid waste, and Tissue Digesters using alkaline hydrolysis for tissue and organic waste—along with custom application engineering and full-service support. The product lines address different waste types (solid, liquid, tissue) but share the company's thermal and chemical decontamination technology platform and non-incineration approach. Additional services include validation, commissioning, and system modernization.

Differentiator

Problem solved

Functional benefit

Brands

• BioSAFE Life Science Solutions: Division focused on life science applications and solutions
• BioSAFE Medical Waste Systems
• BioSAFE Advance Engineering Services

Products and services

• STI Medical Waste Treatment System Continuous, high-throughput medical waste treatment system integrating shredding and steam-based decontamination. Engineered for validatable 6-log pathogen reduction with scalable throughput and efficient volume reduction for downstream handling or recycling. Designed for hospitals and medical facilities processing red bag and other solid infectious wastes on-site, replacing incineration and off-site hauling.
• Effluent Decontamination Systems (EDS) Liquid waste decontamination systems for biocontainment and research environments, available in continuous flow and batch configurations. Use thermal-based neutralization for chemical-free treatment of laboratory wastewater, shower drainage, and autoclave effluent. Configurable for high- and low-solids streams and engineered for BSL-2 through BSL-4 containment levels, with heat recovery options for large-scale installations.
• Tissue Digester Alkaline hydrolysis systems that convert tissue waste generated by labs and research facilities into sterile effluent. Available in lab-scale (5 kg/cycle), mid- and large-scale (40 lb/cycle, 280 lb/cycle, 500 lb/cycle), and trailer-mounted mobilized (4,000 lb/cycle) models. Achieves 97% mass reduction and supports prion destruction for high-containment requirements.
• Custom Applications Engineering Custom-engineered solutions for unique or complex waste disposal challenges, including specialized waste types and deployment scenarios such as emergency containerized EDS for flood response and underwater airbag destruction systems. Also includes system modernization and retrofit services for existing facilities.
• Service, Validation, Commissioning, and System Modernization Comprehensive support services including system installation, validation, commissioning, and on-site training, plus ongoing maintenance and system modernization to extend equipment lifecycle and ensure regulatory compliance. Delivered by factory-direct service technicians and authorized service groups with global coverage, a 2-hour response guarantee, and 24-hour on-site service commitment.

Quantifiable outcome

• Up to 97% mass reduction for tissue waste using alkaline hydrolysis
• +5 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• TakedacoreStrategic or Co-development PartnerTakeda, a major blood plasma company, partnered with BioSAFE to implement efficient waste management solutions that transformed a cost center into a profit center through material recovery and recycling programs. This partnership demonstrates how large pharmaceutical companies are adopting on-site treatment to meet sustainability goals.
• Plasma Protein Therapeutics AssociationcoreStrategic or Co-development PartnerBioSAFE collaborates with the Plasma Protein Therapeutics Association to push for better environmental practices in healthcare waste management across the industry.
• Blood Centers of AmericacoreStrategic or Co-development PartnerCollaboration with Blood Centers of America to improve sustainability and waste management practices among blood collection and processing facilities.
• Plastics ProducersminorStrategic or Co-development PartnerFuture collaborations planned with plastics producers to improve material recyclability from treated medical waste, enabling recovered plastics to re-enter manufacturing supply chains.
• Pharmaceutical CompaniesminorStrategic or Co-development PartnerPlanned partnerships with pharmaceutical companies to improve material recyclability from waste streams and support ESG reporting requirements.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Stericycle: Stericycle is the largest North American regulated medical waste services company, providing collection, transport, and treatment. It is comparable to BioSAFE as the dominant incumbent in the medical waste value chain that BioSAFE's on-site systems directly displace, while also being a potential acquirer or bundler of competing on-site treatment technology.
• Getinge: Getinge is a global provider of sterilization, disinfection, and infection control solutions for hospitals and life sciences. It is comparable to BioSAFE in serving sterilization/decontamination workflows in healthcare and BSL environments, but at significantly greater scale and product breadth.
• Becton Dickinson (BD): BD is a major medical technology company with a substantial medical waste and sharps management business alongside diagnostics and biosciences. It is comparable to BioSAFE as a major incumbent in regulated medical waste handling for hospitals and labs, though it does not focus on capital decontamination systems.
• STERIS: STERIS is a global leader in sterilization, infection prevention, and decontamination products for healthcare, life sciences, and pharmaceutical customers. It is comparable to BioSAFE in serving regulated containment and decontamination workflows (BSL labs, hospitals, pharma) with steam- and chemical-based technologies, though it is far larger and broader in scope.

Direct peers

• BMM Weston: BMM Weston designs and manufactures medical waste treatment systems using steam and shredding technologies for hospitals and waste contractors. It is a direct peer to BioSAFE's STI Medical Waste Treatment System, competing in the same on-site, non-incineration medical waste treatment market.
• Sanitec Services: Sanitec Services provides medical waste treatment equipment and on-site waste management solutions to hospitals and healthcare facilities. It is a direct peer to BioSAFE in selling and servicing on-site regulated medical waste treatment systems, often competing for the same hospital capital projects.
• Tuttnauer: Tuttnauer manufactures steam autoclaves and sterilization equipment for medical, laboratory, and pharmaceutical applications. It is comparable to BioSAFE in the steam-based decontamination technology stack used for medical and biohazardous waste, though Tuttnauer is more focused on standard autoclaves than full custom waste treatment systems.
• Daniels Health: Daniels Health designs reusable sharps and medical waste containers and provides on-site waste management services to hospitals and life sciences. It is comparable to BioSAFE in competing for hospital and lab waste treatment dollars, although its primary offering is container-based services rather than capital decontamination equipment.
• Celitron Medical Waste Solutions: Celitron manufactures autoclave-based medical waste treatment systems used by hospitals and waste handling companies to sterilize infectious waste on-site. It is the closest direct peer to BioSAFE's STI line, competing head-to-head in non-incineration, steam-based solid medical waste treatment.

Emerging players

• Andersen Sterilizers: Andersen Sterilizers makes ethylene oxide and steam-based sterilizers for healthcare, research, and animal labs. It is comparable to BioSAFE as a specialized sterilization/decontamination equipment provider serving research and healthcare containment needs, although its core modality (EtO) is different.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCBKqXSMDn79X7ybZubljhfQ
• LinkedInlinkedin.com/company/biosafeeng/?viewAsMember=true

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioSAFE Engineering